Status:
COMPLETED
Comparison of Two Insulin Detemir Formulations in Healthy Volunteers
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This trial is conducted in Europe. The aim of this trial is to compare two formulations of insulin detemir containing an isotonic agent in healthy volunteers.
Eligibility Criteria
Inclusion
- Considered generally healthy upon completion of medical history and physical examination as judged by the Investigator
- Body mass index (BMI) between 18 and 27 kg/m\^2, inclusive
- Non-smoker
- Fasting plasma glucose maximum 6 mmol/L
Exclusion
- Known or suspected allergy to trial products or related products
- Previous participation in this trial
- Pregnant, breast-feeding or the intention of becoming pregnant or not using adequate contraceptive measures (intrauterine device (IUD) that has been in place for at least 3 months, sterilisation, the oral contraceptive pill (which should have been taken without difficulty for at least 3 months) or an approved hormonal implant)
- The receipt of any investigational drug within the last 3 months prior to this trial
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01498926
Start Date
November 1 2005
End Date
February 1 2006
Last Update
January 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester, United Kingdom, M15 6SH